Suchergebnisse - "Espigado, Ildefonso"

PubPharm (99)

1

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients : results from the EPICOVIDEHA Registry

enthalten in: Haematologica | 2024

von Aiello, T. | Salmanton-Garcia, J. | Marchesi, F. | +99

2

Decoding the historical tale : COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022

enthalten in: EClinicalMedicine | 2024

von Salmanton-García, J. | Marchesi, F. | Farina, F. | +99

3

Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients : final long-term analysis from a prospective multicenter Phase-II Trial

enthalten in: Bone marrow transplantation | 2024

von Cabrero, M. | López-Corral, L. | Jarque, I. | +10

4

Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies : results from the EPICOVIDEHA survey

enthalten in: Infection | 2024

von Lahmer, T. | Salmanton-García, J. | Marchesi, F. | +99

5

The mortality of COVID-19 in CML patients from 2020 until 2022 : results from the EPICOVIDEHA survey

enthalten in: Leukemia & lymphoma | 2024

von El-Ashwah, S. | Salmanton-García, J. | Bilgin, Y. | +58

6

Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic : Results from the EPICOVIDEHA registry

enthalten in: Hematological oncology | 2024

von Musto, P. | Salmanton-García, J. | Sgherza, N. | +84

7

Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic : Results from the EPICOVIDEHA registry

enthalten in: Hematological Oncology | 2024

von Musto, P. | Salmanton‐García, J. | Sgherza, N. | +84

8

Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients : EPICOVIDEHA findings

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Rossi, G. | Salmanton-García, J. | Cattaneo, C. | +99

9

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

enthalten in: International journal of antimicrobial agents | 2023

von Salmanton-García, J. | Marchesi, F. | Koehler, P. | +58

10

Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy : an EPICOVIDEHA survey

enthalten in: Blood advances | 2023

von van Doesum, J. | Salmanton-García, J. | Marchesi, F. | +47

CommentIn: Blood Adv. 2023 Jun 13;7(11):2643-2644. - PMID 37310762

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]